Elicio Therapeutics
ELTX
41 hedge funds and large institutions have $92M invested in Elicio Therapeutics in 2021 Q1 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
16.48% more ownership
Funds ownership: 0% → 16.48% (+16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$18.7M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$16.9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.9M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$11.9M |
| 5 |
BlackRock
New York
|
+$6.05M |
Top Sellers
ELTX Hedge Fund Activity: Q1 2021 in Review
41 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Elicio Therapeutics (ELTX) for Q1 2021, worth a combined $92M.
Buyers outnumbered sellers: 41 funds opened new ELTX positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Park West Asset Management, opening a new position worth an estimated $18.7M.
- 41 institutional investors held Elicio Therapeutics (ELTX) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $92M of Elicio Therapeutics stock for Q1 2021.
- 41 funds opened new Elicio Therapeutics positions in Q1 2021 and 0 closed out, a net change of +41 holders.
- The largest Elicio Therapeutics buyer in Q1 2021 was Park West Asset Management, an estimated $18.7M added.
Based on aggregated 13F filings for Q1 2021.